This assay is to provide Kasumi-1-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Kasumi-1
Target Cell Organism
Human
Target Cell Background
Kasumi-1 is a myeloblast cell that was isolated from the peripheral blood of an acute myeloblastic leukemia Asian male patient. This cell line was deposited by H Asou in 1989.
Related Diseases
Acute Myeloblastic Leukemia; AML
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
Kasumi-1-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.